California Public Employees Retirement System Keros Therapeutics, Inc. Transaction History

California Public Employees Retirement System

  • $135 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021
SELL
$42.4 - $70.11 $1.12 Million - $1.85 Million
-26,373 Closed
0 $0
Q1 2021

May 14, 2021
SELL
$54.0 - $75.28 $132,408 - $184,586
-2,452 Reduced 8.51%
26,373 $1.62 Million
Q4 2020

Feb 02, 2021
BUY
$36.0 - $82.74 $461,016 - $1.06 Million
12,806 Added 79.94%
28,825 $2.03 Million
Q3 2020

Nov 05, 2020
BUY
$27.04 - $62.21 $16,224 - $37,326
600 Added 3.89%
16,019 $618,000
Q2 2020

Aug 12, 2020
BUY
$20.08 - $40.39 $309,613 - $622,773
15,419 New
15,419 $578,000

Others Institutions Holding KROS

# of Institutions
157
Shares Held
27.1M
Call Options Held
28.7K
Put Options Held
1.8K
View Full List

About Keros Therapeutics, Inc.

KROS Quotes by TradingView
  • Ticker KROS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,757,000
  • Market Cap $1.45B
  • Description
  • Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...
More about KROS
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email